info@lifesciencecollaborative.org

Life Sciences Collaborative

The Life Sciences Collaborative (LSC) is a select group of founders and investors that share a common vision for enhancing the success of emerging businesses in the biotechnology, medtech, and digital health sectors through peer-to-peer learning, connecting and building professional relationships.  

The Collaborative has built thriving groups over the last ten years in the Princeton, NJ, Philadelphia/King of Prussia, PA, and most recently in Boston, MA, regions all of which are homes to leading life science innovation clusters.

One of the Collaborative’s great strengths is the opportunity for members to build connections across these key regions

Who we are

The Life Sciences Collaborative is a select group of industry veterans and executives from the pharmaceutical, biotechnology, and medical device sectors, and industry service providers who share a common vision of increasing the success of emerging life sciences businesses in the Mid-Atlantic Region.

LSC activities are built around small, informal, monthly breakfast educational and networking meetings. These sessions focus on topics around innovation and investment, including industry trends, practical issues related to growing and managing innovative businesses, and best practices.

The meetings also include presentations by emerging companies, providing them with opportunities to get expert feedback on their technologies and to expand their networks.

Mission Statement

The mission of the Life Sciences Collaborative is to promote connectivity among leaders in emerging life sciences businesses through networking, education, training, and mentorship with the goal of advancing professional development and business growth in the Mid-Atlantic Region.

LSC is a volunteer organization. It is neither sponsorship nor membership dues driven. If you are interested in participating in LSC’s monthly breakfast meetings, please contact us.

OUR MEMBERS

CEOs, Directors, Private Equity and Venture partners, Angel investors. Members may have successful track record leading public or private companies.

Jordan Leef

Position: Pyramid Biosciences
Categories: 3. MEMBERS, Boston, MA

Jordan Leef

Pyramid Biosciences

Josh Lang

Position: Asymchem
Categories: 3. MEMBERS, Boston, MA

Josh Lang

Asymchem

Josh Wachman

Position: Hunter BioDiscovery
Categories: 3. MEMBERS, Boston, MA

Josh Wachman

Hunter BioDiscovery

Kathleen Brunner

Position: CEO at Acumen Analytics | CIO
Email: kbrunner@acumenanalytics.com
Categories: 3. MEMBERS, 3. MEMBERS, Boston, MA, Pennsylvania

Kathleen Brunner

CEO at Acumen Analytics | CIO

Ken Blank, Ph.D

Position: University Research Strategies
Categories: 2. PLANNING COMMITTEE, 3. MEMBERS, Boston, MA, LSC – New Jersey

Ken Blank, Ph.D

University Research Strategies

Kyle Abbott

Position: CEO Venture Forward
Categories: 3. MEMBERS, Boston, MA

Kyle Abbott

CEO Venture Forward

Lex Van der Ploeg

Position: VDP, LLC
Categories: 3. MEMBERS, Boston, MA

Lex Van der Ploeg

VDP, LLC

Mark Connell

Position: President & Co-Founder, SLBST Pharma
Categories: 3. MEMBERS, Boston, MA

Mark Connell

President & Co-Founder, SLBST Pharma

Mark Moody

Position: Activate Therapeutics, LLC
Categories: 2. PLANNING COMMITTEE, 3. MEMBERS, Boston, MA

Mark Moody

Activate Therapeutics, LLC

Mark Tepper, Ph.D

Position: EuMentis Therapeutics
Categories: 2. PLANNING COMMITTEE, 3. MEMBERS, Boston, MA

Mark Tepper, Ph.D

EuMentis Therapeutics